Gregory J. Brunn

5.2k total citations · 3 hit papers
37 papers, 4.3k citations indexed

About

Gregory J. Brunn is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Gregory J. Brunn has authored 37 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 16 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Gregory J. Brunn's work include Immune Response and Inflammation (15 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Gregory J. Brunn is often cited by papers focused on Immune Response and Inflammation (15 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Gregory J. Brunn collaborates with scholars based in United States, Australia and United Kingdom. Gregory J. Brunn's co-authors include Jeffrey L. Platt, Geoffrey B. Johnson, John C. Lawrence, Robert T. Abraham, Yuzo Kodaira, Francis J. Dumont, Mary M. Martin, Gregory J. Wiederrecht, Candace J. Sabers and Christine C. Hudson and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gregory J. Brunn

36 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

1997 801 citations Gregory J. Brunn, John C. Lawrence et al. profile →
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

1995 715 citations Candace J. Sabers, Mary M. Martin et al. Journal of Biological Chemistry profile →
Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 4

2002 536 citations Geoffrey B. Johnson, Gregory J. Brunn et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory J. Brunn United States	26	2.6k	1.2k	585	536	448	37	4.3k
Satoshi Matsuda Japan	32	2.4k 0.9×	1.7k 1.5×	449 0.8×	642 1.2×	327 0.7×	72	5.0k
Vily Panoutsakopoulou Greece	16	3.3k 1.3×	1.2k 1.0×	446 0.8×	702 1.3×	266 0.6×	27	5.3k
Julián Gómez-Cambronero United States	35	2.1k 0.8×	1.0k 0.9×	571 1.0×	546 1.0×	182 0.4×	113	3.6k
Olivier Donzé Switzerland	25	2.3k 0.9×	979 0.8×	301 0.5×	308 0.6×	253 0.6×	35	3.5k
Pravin B. Sehgal United States	32	1.3k 0.5×	1.3k 1.1×	421 0.7×	893 1.7×	246 0.5×	79	3.5k
Véronique Baron France	33	2.0k 0.8×	1.1k 0.9×	313 0.5×	772 1.4×	224 0.5×	57	3.7k
Philippe Naquet France	39	1.9k 0.8×	1.9k 1.6×	304 0.5×	672 1.3×	303 0.7×	101	4.6k
Miguel A. Vega Spain	31	1.5k 0.6×	1.3k 1.1×	273 0.5×	530 1.0×	815 1.8×	60	3.5k
Subburaj Ilangumaran Canada	35	1.6k 0.6×	1.5k 1.3×	492 0.8×	1.1k 2.0×	209 0.5×	101	3.6k
Daisuke Okuzaki Japan	38	2.4k 1.0×	1000 0.9×	518 0.9×	650 1.2×	341 0.8×	248	4.6k

Countries citing papers authored by Gregory J. Brunn

Since Specialization

Citations

This map shows the geographic impact of Gregory J. Brunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Brunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Brunn more than expected).

Fields of papers citing papers by Gregory J. Brunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Brunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Brunn. The network helps show where Gregory J. Brunn may publish in the future.

Co-authorship network of co-authors of Gregory J. Brunn

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Brunn. A scholar is included among the top collaborators of Gregory J. Brunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Brunn. Gregory J. Brunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fisher, James, Travis J. McKenzie, Joseph B. Lillegard, et al.. (2012). Role of Kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure. Journal of Surgical Research. 180(1). 147–155. 80 indexed citations

Juskewitch, Justin E., Jeffrey L. Platt, Bruce E. Knudsen, et al.. (2012). Disparate roles of marrow- and parenchymal cell-derived TLR4 signaling in murine LPS-induced systemic inflammation. Scientific Reports. 2(1). 918–918. 25 indexed citations

Tang, Amy, Gregory J. Brunn, Marília Cascalho, & Jeffrey L. Platt. (2007). Pivotal Advance: Endogenous pathway to SIRS, sepsis, and related conditions. Journal of Leukocyte Biology. 82(2). 282–285. 51 indexed citations

Xu, Xiulong, Geetha Rao, Roderick M. Quiros, et al.. (2006). In Vivo and in Vitro Degradation of Heparan Sulfate (HS) Proteoglycans by HPR1 in Pancreatic Adenocarcinomas. Journal of Biological Chemistry. 282(4). 2363–2373. 21 indexed citations

Jayachandran, Muthuvel, et al.. (2006). In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. Journal of Applied Physiology. 102(1). 429–433. 63 indexed citations

Johnson, Geoffrey B., Gregory J. Brunn, Benjamin Samstein, & Jeffrey L. Platt. (2005). New insight into the pathogenesis of sepsis and the sepsis syndrome. Surgery. 137(4). 393–395. 26 indexed citations

Cole, Caroline, Jian Qiao, Timothy Kottke, et al.. (2005). Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells. Nature Medicine. 11(10). 1073–1081. 121 indexed citations

Johnson, Geoffrey B., Gregory J. Brunn, & Jeffrey L. Platt. (2004). Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 4. The Journal of Immunology. 172(1). 20–24. 204 indexed citations

Platt, Jeffrey L., et al.. (2004). Selective suppression of Toll‐like receptor 4 activation by chemokine receptor 4. FEBS Letters. 579(3). 699–704. 26 indexed citations

10.

Johnson, Geoffrey B., Gregory J. Brunn, & Jeffrey L. Platt. (2003). Activation of Mammalian Toll-like Receptors by Endogenous Agonists. Critical Reviews in Immunology. 23(1-2). 15–44. 117 indexed citations

11.

Johnson, Geoffrey B., Gregory J. Brunn, Yuzo Kodaira, & Jeffrey L. Platt. (2002). Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 4. The Journal of Immunology. 168(10). 5233–5239. 536 indexed citations breakdown →

12.

Lawrence, John C. & Gregory J. Brunn. (2001). Insulin Signaling and the Control of PHAS-I Phosphorylation. Progress in molecular and subcellular biology. 26. 1–31. 21 indexed citations

13.

Mothe‐Satney, Isabelle, Gregory J. Brunn, Lloyd P. McMahon, et al.. (2000). Mammalian Target of Rapamycin-dependent Phosphorylation of PHAS-I in Four (S/T)P Sites Detected by Phospho-specific Antibodies. Journal of Biological Chemistry. 275(43). 33836–33843. 110 indexed citations

14.

Dempsey, Laurie A., Gregory J. Brunn, & Jeffrey L. Platt. (2000). Heparanase, a potential regulator of cell–matrix interactions. Trends in Biochemical Sciences. 25(8). 349–351. 147 indexed citations

15.

Yang, Da‐Qing, Gregory J. Brunn, & John C. Lawrence. (1999). Mutational analysis of sites in the translational regulator, PHAS‐I, that are selectively phosphorylated by mTOR. FEBS Letters. 453(3). 387–390. 41 indexed citations

16.

Brunn, Gregory J., Patrick Fadden, Timothy Haystead, & John C. Lawrence. (1997). The Mammalian Target of Rapamycin Phosphorylates Sites Having a (Ser/Thr)-Pro Motif and Is Activated by Antibodies to a Region near Its COOH Terminus. Journal of Biological Chemistry. 272(51). 32547–32550. 144 indexed citations

17.

Wiederrecht, Gregory J., Candace J. Sabers, Gregory J. Brunn, et al.. (1995). Mechanism of action of rapamycin: New insights into the regulation of G1-phase progression in eukaryotic cells. PubMed. 1. 53–71. 137 indexed citations

18.

Brunn, Gregory J., et al.. (1995). Protein-tyrosine Kinase-dependent Activation of STAT Transcription Factors in Intel leukin-2- or Interleukin-4-stimulated T Lymphocytes. Journal of Biological Chemistry. 270(19). 11628–11635. 39 indexed citations

19.

Sabers, Candace J., Mary M. Martin, Gregory J. Brunn, et al.. (1995). Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells. Journal of Biological Chemistry. 270(2). 815–822. 715 indexed citations breakdown →

20.

Pentel, Paul R., Gregory J. Brunn, Susan M. Pond, & Daniel E. Keyler. (1991). Pretreatment with drug-specific antibody reduces desipramine cardiotoxicity in rats. Life Sciences. 48(7). 675–683. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact